The Naderi Center Highlights Simple Recovery and Long-Term Results of Earlobe Repair Surgery
Serving Washington, DC, Northern Virginia, and Maryland, The Naderi Center shares what patients can expect after earlobe repair surgery, including...
Day: February 17, 2026
The Naderi Center Highlights Simple Recovery and Long-Term Results of Earlobe Repair Surgery
Serving Washington, DC, Northern Virginia, and Maryland, The Naderi Center shares what patients can expect after earlobe repair surgery, including...
Alpha Genesis Successfully Completes USDA Triennial Re-Licensing Inspection as Company Accelerates National Expansion
YEMASSEE, SOUTH CAROLINA / ACCESS Newswire / February 17, 2026 / Alpha Genesis, Inc., America's largest primate research center, proudly...
Alpha Genesis Successfully Completes USDA Triennial Re-Licensing Inspection as Company Accelerates National Expansion
YEMASSEE, SOUTH CAROLINA / ACCESS Newswire / February 17, 2026 / Alpha Genesis, Inc., America's largest primate research center, proudly...
Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))
New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the active ingredient...
Aspire Biopharma Files Provisional Patent Application for a Fast-Acting Sublingual Powder Formulation of Meclizine (Generic Dramamine(R))
New delivery system targets rapid-onset relief for motion sickness and vertigo, modernizing the $450M global market for the active ingredient...
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company’s Recently Initiated Strategic Transformation
New Members of the Strengthened Leadership Team Add Decades of Operational Execution, Pipeline Optimization and Transactional Expertise to Support Company...
African Leaders Call for Sustainable Malaria Financing as Progress Stalls and Funding Crisis Deepens
The 2025 Africa Malaria Progress Report reveals 270.8 million cases and nearly 600,000 deaths; It warns of potential resurgence, as...
Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models
Iron-rescue experiments confirm tumor cell mortality is mechanistically driven, not nonspecific cytotoxicity. MIAMI, FL / ACCESS Newswire / February 17,...
Black Book’s 2026 State of Behavioral Health IT Report Ranks Netsmart #1
Survey of 1,104 behavioral health professionals finds denials and prior authorization burden rising as AI adoption accelerates. NEW YORK CITY,...
Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE
mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe CAMBRIDGE,...
Polaryx Therapeutics Selects Contract Research Organization for SOTERIA Phase 2 Basket Trial
PARAMUS, NJ, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying...
STRATA Skin Sciences Highlights Meta-Analysis Confirming Clinical Efficacy of 308 nm Excimer Laser for Plaque Psoriasis
Growing body of clinical data like February 2026 publication from Georgetown University supports optimized, targeted Excimer laser UVB strategies for...
Nanox to Showcase Nanox.ARC Live in Europe for First Time and Present New AI Capabilities at ECR 2026
Live demonstrations of the Nanox.ARC will feature at the ECR booth #425 in Hall X4Oral presentation by Dr. Nogah Shabshin...
BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
MENLO PARK, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a...
Outlook Therapeutics Reports First Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update
Continued expansion of LYTENAVA™ (bevacizumab gamma) in Europe underway, including commercial launch in Austria in January 2026Additional European launches expected...
Cellectar Biosciences Expands Global Intellectual Property Estate
Strengthens Protection Around Broad Portfolio of Cancer-Targeting Drug Conjugates and Enabling Technologies Provides Key Coverage Across Europe Ahead of Planned...
Extendicare Announces February 2026 Dividend of C$0.042 per Share
MARKHAM, Ontario, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has...
Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers
Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the...
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
MARIETTA, Ga., Feb. 17, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that...